These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine]. Moroz AF, Antsiferova NG, Radkevich SA, Mishina VS. Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165 [Abstract] [Full Text] [Related]
9. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection. Montie TC, Drake D, Sellin H, Slater O, Edmonds S. Antibiot Chemother (1971); 1987 Oct; 39():233-48. PubMed ID: 3118785 [No Abstract] [Full Text] [Related]
16. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4]. Nuriddinova NR, Ivanova LE, Sheremet'ev NN, Garib FIu. Zh Mikrobiol Epidemiol Immunobiol; 2002 Jun; (4):40-3. PubMed ID: 12449697 [Abstract] [Full Text] [Related]
17. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey). Joó I, Stanislavskii ES. J Hyg Epidemiol Microbiol Immunol; 1982 Jun; 26(4):417-27. PubMed ID: 6819316 [Abstract] [Full Text] [Related]